NYSE · Drug Manufacturers - Specialty & Generic

Perrigo Company plc (PRGO) Stock

$15.96 -2.50% NYSE: PRGO Healthcare

Valuation

MetricValue
Price$15.96
Market Cap$2.21B
P/E Ratio-1.14
P/B Ratio0.79
P/S Ratio0.48
EPS (TTM)$-10.29
52-Week High$22.48
52-Week Low$9.23
Dividend Yield8.13%

Financials & Margins

MetricValue
ROE-55.97%
ROA-22.80%
ROCE3.28%
Gross Margin8.06%
Operating Margin8.06%
Net Margin-41.85%
Debt/Equity1.31
Current Ratio2.76

Annual Financials (USD)

Metric20212022202320242025
Revenue$4.1B$4.5B$4.7B$4.4B$4.3B
Operating Profit$410.0M$79.0M$152.0M$113.0M$343.0M
Net Profit$-69.0M$-141.0M$-13.0M$-172.0M$-1.4B
EPS$-0.98$-0.97$-0.09$-1.25$-10.29
Op Margin9.9%1.8%3.3%2.6%8.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$10.4B$11.0B$10.8B$9.6B$8.5B
Total Liabilities$5.3B$6.2B$6.0B$5.3B$5.6B
Cash$1.9B$601.0M$751.0M$559.0M$532.0M
Borrowings$3.7B$4.3B$4.1B$3.6B$4.0B

Latest News

Perrigo Announces Appointment of Two New Independent Directors to Board PR Newswire · Jun 30, 2026 Stryker (SYK) Moves 5.3% Higher: Will This Strength Last? Zacks · Jun 29, 2026 FDA Seeks Updated Labeling for Testosterone Therapies MT Newswires · Jun 18, 2026 Jim Cramer on Perrigo Comapny: “This Is a Value Trap” Insider Monkey · Jun 17, 2026 Perrigo Leadership Shakeup Puts Governance And Long Term Strategy In Focus Simply Wall St. · Jun 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$156.0M$307.0M$406.0M$363.0M$239.0M
Investing Cash Flow$1.1B$-2.1B$-179.0M$-39.0M$-169.0M
Financing Cash Flow$-18.0M$-20.0M$-7.0M$-21.0M$-26.0M
Net Cash Flow$1.2B$-1.3B$151.0M$-192.0M$-27.0M
Free Cash Flow$4.0M$211.0M$304.0M$245.0M$145.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-3.97
FCF Yield8.87%
Quick Ratio1.32
Interest Coverage1.32
Return 1Y-61.86%
Return 3Y-67.28%
Return 5Y-74.03%

Ownership

Insiders Held0.40%
Institutions Held116.80%
Institutions Float Held117.27%
Institutional HolderSharesReport Date
Blackrock Inc.17,120,0842026-03-31
Price (T.Rowe) Associates Inc13,376,7762026-03-31
Neuberger Berman Group, LLC10,460,0802026-03-31
Vanguard Portfolio Management LLC8,141,9192026-03-31
Fuller & Thaler Asset Management Inc.7,662,8832026-03-31

About Perrigo Company plc

Perrigo Company plc is led by CEO Patrick Lockwood-Taylor, publicly traded since 1991.

Perrigo Company plc (PRGO) stock trades at $15.96 with a market capitalization of $2.21B. The stock is valued at a negative price-to-earnings (P/E) ratio of -1.14, reflecting a net loss over the last twelve months, price-to-book of 0.79, price-to-sales of 0.48. Over the past 52 weeks the stock has ranged between $9.23 and $22.48, and currently trades 29.0% below its 52-week high. It pays a dividend yielding 8.13%.

On profitability, Perrigo Company plc generates a return on equity (ROE) of -55.97% (negative, reflecting a net loss), return on capital employed of 3.28%, an operating margin of 8.06%, a net profit margin of -41.85%.

Perrigo Company plc by the numbers, 2016–2025

Between 2016 and 2025 Perrigo Company plc reported revenue of $5.3B rising to $4.3B, a change of -19.5% across 10 years. Compounded, revenue has grown 0.8% a year over five years, -1.5% over three, -2.7% over the last twelve months. Net profit rose to $-1.4B.

Operating margin went from -37.9% in 2016 to 8.1% in 2025, a gain of 45.9 percentage points. The most recent net margin is -41.85%. On a trailing twelve-month basis to Jun '26, revenue is $4.1B and net profit $-1.7B.

Borrowings fell from $5.8B to $4.0B, cash from operations was $239.0M in the latest year, positive in 10 of the last 10.

Return on equity has averaged -11.4% over five years, and was -48.5% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Perrigo Company plc (PRGO) — frequently asked questions

What is Perrigo Company plc (PRGO) stock price today?

Perrigo Company plc (PRGO) is currently trading at $15.96, down 2.5% today.

What is PRGO P/E ratio?

Perrigo Company plc's P/E ratio is -1.14. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is PRGO return on equity (ROE)?

Perrigo Company plc's return on equity (ROE) is -55.97%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is Perrigo Company plc's market cap?

Perrigo Company plc has a market capitalization of $2.21B.

Does PRGO pay a dividend?

Yes. Perrigo Company plc currently yields 8.13%. Yield moves with the share price, so it changes daily even when the payment does not.

How much debt does PRGO carry?

Perrigo Company plc has a debt-to-equity ratio of 1.31. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is PRGO's profit margin?

Perrigo Company plc reports a net profit margin of -41.85% — the share of revenue left after every cost, including tax and interest.

What sector is PRGO in?

Perrigo Company plc is classified under Healthcare, in the Drug Manufacturers - Specialty & Generic industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is PRGO listed on?

Perrigo Company plc trades on NYSE under the ticker PRGO.

What is PRGO's 52-week range?

Over the last year Perrigo Company plc has traded between $9.23 and $22.48.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens PRGO currently matches

On the figures above, Perrigo Company plc passes the filters for 14 of our ready-made screens, among them Low PB Stocks, High Dividend Stocks, Dividend Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Low PB StocksHigh Dividend StocksDividend StocksHigh Yield Dividend StocksDividend Yield Over 5%Dividend Yield Over 7%Dividend Yield Over 8%Stocks Under $100Stocks Under $50Dividend Yield Over 3%Mid Cap StocksNYSE Listed StocksNYSE High Dividend StocksHigh Current Ratio Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.